Abstract
RATIONALE: Quality of life (QOL) is a crucial issue in the management of chronic asthma, usually evaluated through well validated but time-consuming questionnaires. So far, there is no objective marker of asthma related QOL (AQOL). Therefore, we evaluated the ability of exhaled nitric oxide (eNO), a marker of airway inflammation, to detect a change in AQOL.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
